Testing effectiveness (Phase 2)Study completedNCT02333565
What this trial is testing
Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas
Who this might be right for
Recurrent MeningiomasResistant Meningiomas
Assistance Publique Hopitaux De Marseille 20